Literature DB >> 6087020

Steroid receptor status of focal-nodular hyperplasia of the human liver.

H Bojar, D Petzinna, C Brölsch, W Staib.   

Abstract

As with normal human liver, both focal nodular hyperplasia (FNH) of the liver and a hepatocellular carcinoma were found to contain low levels of high affinity estrogen-binding components. In low-salt sucrose gradients the estrogen binders sedimented at 4S and 8S. Specificity studies indicated a requirement for estrogenic hormones. Progestin-binding studies using labeled and unlabeled ORG 2058 revealed high levels of specific binding in FNH and normal liver cytosol, whereas only insignificant amounts of ORG 2058 binding was found in the hepatocellular carcinoma. As judged by the high apparent dissociation constant (4-14 X 10(-8) mol/l) of the ORG 2058 - binder complex, the apparent lack of 8S binding in low-salt sucrose gradients and the atypical ligand specificity, the progestin receptor nature of these binding entities is unlikely. In contrast, normal liver, FNH, and the hepatocellular carcinoma were found to contain significant quantities of glucocorticoid receptors.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6087020     DOI: 10.1007/bf01726905

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  13 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Liver tumors and contraceptive steroids: experience with the first one hundred registry patients.

Authors:  W M Christopherson; E T Mays
Journal:  J Natl Cancer Inst       Date:  1977-02       Impact factor: 13.506

3.  Binding of progesterone and R 5020, a highly potent progestin, to human endometrium and myometrium.

Authors:  D Philibert; J P Raynaud
Journal:  Contraception       Date:  1974-11       Impact factor: 3.375

4.  Radio-ligand binding assay of specific estrogens using a soluble uterine macromolecule.

Authors:  S G Korenman
Journal:  J Clin Endocrinol Metab       Date:  1968-01       Impact factor: 5.958

5.  Identification and partial characterization of glucocorticoid receptors in human liver.

Authors:  H Bojar; S Westerkamp; W Staib; C Broelsch
Journal:  Hepatogastroenterology       Date:  1980-06

6.  Estradiol receptors in human liver.

Authors:  M J Duffy; G J Duffy
Journal:  J Steroid Biochem       Date:  1978-03       Impact factor: 4.292

7.  Hepatic estrogen and progesterone receptors in an estrogen-associated hepatic neoplasm.

Authors:  J S Macdonald; M E Lippman; P V Woolley; P P Petrucci; P S Schein
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

8.  Investigation on the thermostability of steroid hormone receptors in lyophilized calf uterine tissue powder.

Authors:  H Bojar; W Staib; K Beck; J Pilaski
Journal:  Cancer       Date:  1980-12-15       Impact factor: 6.860

9.  Primary liver tumors and oral contraceptives. Results of a survey.

Authors:  J Vana; G P Murphy; B L Aronoff; H W Baker
Journal:  JAMA       Date:  1977-11-14       Impact factor: 56.272

10.  Hepatomas: hormone receptors and therapy.

Authors:  M A Friedman; D J Demanes; P G Hoffman
Journal:  Am J Med       Date:  1982-09       Impact factor: 4.965

View more
  1 in total

1.  Estrogen receptors in hepatocellular carcinoma: is endocrine therapy for hepatocellular carcinoma likely to be effective?

Authors:  K Kohigashi; Y Fukuda; H Imura
Journal:  Gastroenterol Jpn       Date:  1987-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.